Alzheimer’s Disease Treatment Market Growth Opportunities and Forecast till 2030
CHAPTER 1. Industry Overview of Alzheimer’s Disease Treatment Market
1.1. Definition and Scope
1.1.1. Definition of Alzheimer’s Disease Treatment
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Alzheimer’s Disease Treatment Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Alzheimer’s Disease Treatment Market By Drug Class
1.2.3. Alzheimer’s Disease Treatment Market By Distribution Channel
1.2.4. Alzheimer’s Disease Treatment Market By Regions
CHAPTER 2. Research Approach
2.1. Distribution Channelology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Sources
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Alzheimer’s Disease Treatment Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Alzheimer’s Disease Treatment Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Alzheimer’s Disease Treatment Market By Drug Class
4.1. Introduction
4.2. Alzheimer’s Disease Treatment Market Revenue (USD Million) By Drug Class
4.2.1. Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
4.2.2. Cholinergic
4.2.2.1. Cholinergic Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. Memantine
4.2.3.1. Memantine Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.4. Combined Drug
4.2.4.1. Combined Drug Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.5. AChE Inhibitors
4.2.5.1. AChE Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.6. Immunoglobulins
4.2.6.1. Immunoglobulins Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Alzheimer’s Disease Treatment Market By Distribution Channel
5.1. Introduction
5.2. Alzheimer’s Disease Treatment Market Revenue (USD Million) By Distribution Channel
5.2.1. Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
5.2.2. Hospital Pharmacy
5.2.2.1. Hospital Pharmacy Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Online Sales
5.2.3.1. Online Sales Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Retail Pharmacy
5.2.4.1. Retail Pharmacy Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Alzheimer’s Disease Treatment Market By Country
6.1. North America Alzheimer’s Disease Treatment Market Overview
6.2. U.S.
6.2.1. U.S. Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
6.2.2. U.S. Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
6.3. Canada
6.3.1. Canada Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
6.3.2. Canada Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Alzheimer’s Disease Treatment Market By Country
7.1. Europe Alzheimer’s Disease Treatment Market Overview
7.2. U.K.
7.2.1. U.K. Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
7.2.2. U.K. Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
7.3. Germany
7.3.1. Germany Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
7.3.2. Germany Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
7.4. France
7.4.1. France Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
7.4.2. France Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
7.5. Spain
7.5.1. Spain Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
7.5.2. Spain Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
7.6. Rest of Europe
7.6.1. Rest of Europe Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
7.6.2. Rest of Europe Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Alzheimer’s Disease Treatment Market By Country
8.1. Asia Pacific Alzheimer’s Disease Treatment Market Overview
8.2. China
8.2.1. China Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
8.2.2. China Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.3. Japan
8.3.1. Japan Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
8.3.2. Japan Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.4. India
8.4.1. India Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
8.4.2. India Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.5. Australia
8.5.1. Australia Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
8.5.2. Australia Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.6. South Korea
8.6.1. South Korea Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
8.6.2. South Korea Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
8.7.2. Rest of Asia-Pacific Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Alzheimer’s Disease Treatment Market By Country
9.1. Latin America Alzheimer’s Disease Treatment Market Overview
9.2. Brazil
9.2.1. Brazil Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
9.2.2. Brazil Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.3. Mexico
9.3.1. Mexico Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
9.3.2. Mexico Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin America Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
9.4.2. Rest of Latin America Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Alzheimer’s Disease Treatment Market By Country
10.1. Middle East & Africa Alzheimer’s Disease Treatment Market Overview
10.2. GCC
10.2.1. GCC Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
10.2.2. GCC Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
10.3. South Africa
10.3.1. South Africa Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
10.3.2. South Africa Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
10.4.2. Rest of Middle East & Africa Alzheimer’s Disease Treatment Market Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Alzheimer’s Disease Treatment Market
11.1. Alzheimer’s Disease Treatment Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Alzheimer’s Disease Treatment market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 12. Company Profile
12.1. AB Science
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Million), 2021
12.1.3.2. AB Science 2021 Alzheimer’s Disease Treatment Business Regional Distribution
12.1.4. Drug Class/ Service and Specification
12.1.5. Recent Developments & Business Strategy
12.1.6. Manufacturing Plant Footprint Analysis
12.2. AbbVie Inc.
12.3. Allergan
12.4. AC Immune
12.5. AstraZeneca
12.6. Bayer AG
12.7. Biogen
12.8. Bristol-Myers Squibb Company
12.9. DAIICHI SANKYO COMPANY, LIMITED.
12.10. Eisai Co., Ltd.
12.11. Eli Lilly and Company
12.12. F. Hoffmann-La Roche Ltd
12.13. H. Lundbeck A/S
12.14. Johnson & Johnson Services, Inc.
12.15. Merz Pharma
12.16. Novartis AG
12.17. ONO PHARMACEUTICAL CO., LTD.
12.18. Pfizer Inc.
12.19. Takeda Pharmaceutical Company Limited.
12.20. TauRx
12.21. Teva Pharmaceutical Industries Ltd.
12.22. VTV Therapeutics